ENOV MEXC RealStocks
Own real ENOV shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-16 23:02:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Enovis Corporation (ENOV) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NYSE. The stock is currently priced at $27.93, with a market capitalization of $1.60B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $16.70 to $31.67. This page covers its latest market performance, valuation, price trends and company information.
$1.60B | |
$27.99 | |
$28.30 | |
$27.44 | |
$27.68 | |
841.03K | |
1.70M | |
-- | |
$31.67 | |
$16.70 | |
-- | |
-- |
Enovis Corporation (ENOV) is trading at $27.92 in after-hours trading as of 2026-11-16 21:10:00, down 0.04% ($0.01) from the regular-session close of $27.93.
After-hours trading shows how investors are pricing ENOV after the regular session closes. The current after-hours price is near the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, Enovis Corporation (ENOV) moved from $28.62 to $27.93, representing a decline of 2.42% ($0.69).
The stock traded between $26.62 and $29.89 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 2.08 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 75.0%
ENOV is currently trading at $27.93, placing it 75.0% of the way from its 52-week low of $16.70 to its 52-week high of $31.67. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 7,802 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Enovis Corporation (ENOV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ENOV, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between ENOV shares and USD.
ENOV Shares to USD
1.00 ENOV shares = 27.926 USD
Calculations are estimates based on the latest available price and are for reference only.